Related Experiment Video
Updated: Dec 20, 2025

High-Throughput Metabolic Profiling for Model Refinements of Microalgae
Published on: December 4, 2021
Comparison of a simple and a complex model for BCF prediction using in vitro biotransformation data
1Helmholtz Centre for Environmental Research, Department of Analytical Environmental Chemistry, Permoserstr. 15, 04318, Leipzig, Germany.
Predicting bioconcentration factors (BCFs) with in vitro data offers a promising alternative to animal testing. This study found that a simple one-compartment model provides results comparable to a complex multi-compartment model for bioaccumulation assessment.
Area of Science:
- Environmental Toxicology
- Biochemical Pharmacology
Background:
- Bioconcentration factors (BCFs) are crucial for assessing chemical bioaccumulation.
- Current in vitro models often show poor agreement with experimental BCFs and neglect extrahepatic biotransformation.
- Reducing animal testing in bioaccumulation assessments is a key regulatory and ethical goal.
Purpose of the Study:
- To compare the performance of a simple one-compartment model versus a multi-compartment model for predicting BCFs using in vitro biotransformation data.
- To evaluate the utility of these models in incorporating extrahepatic biotransformation data.
- To determine the most suitable model for regulatory bioaccumulation assessment.
Main Methods:
- Implementation of both one-compartment and multi-compartment BCF prediction models within a single calculation tool.
- Utilizing in vitro biotransformation data as input for both models.
- Configuration of models to optionally include extrahepatic biotransformation data (e.g., from gills or gastrointestinal tract).
Main Results:
- Both the one-compartment and multi-compartment models produced nearly identical BCF predictions when using plausible physiological data.
- The models demonstrated flexibility in incorporating extrahepatic biotransformation data.
- No significant discrepancies were observed between the models for the evaluated cases.
Conclusions:
- The simple one-compartment model is sufficient for regulatory bioaccumulation assessments using in vitro data, offering a practical and reliable approach.
- The multi-compartment model offers greater refinement and may be preferred for studies requiring detailed representation of in vivo characteristics like first-pass effects.
- Both models provide valuable tools for advancing in vitro methods in chemical risk assessment and reducing animal use.
Related Concept Videos
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Drug Biotransformation: Overview
Drug Biotransformation: Overview
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...

